Jan 7 (Reuters) – Online pharmacy platform SaveRxCanada.to said on Wednesday it has started offering Novo Nordisk’s blockbuster diabetes drug Ozempic, sourced from India, to U.S. patients as demand grows for cheaper options.
The Canada-based company said the Ozempic shot, which originates in India, sells for about $280 a shot, while U.S. retail pharmacies typically charge $900 to $1,100 a shot, depending on the dose and location.
A Novo Nordisk spokesman said the company would investigate the matter, while the U.S. Food and Drug Administration did not immediately respond to a request for comment.
SaveRxCanada.to also did not immediately respond to a request for more purchase details.
The platform offers a variety of prefilled pens, including 0.25 mg, 0.5 mg and 1 mg doses, and says the product clearly discloses the manufacturer and country of origin.
It added that all orders require a valid prescription and include free shipping.
“As prices continue to rise in the U.S., many patients are actively comparing prescription costs,” the company said in a statement.
The platform calls itself an international prescription referral service and says it has been operating for 24 years, connecting patients with licensed pharmacies outside the United States.
International pharmacy services are generating interest among U.S. consumers facing rising out-of-pocket costs.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Krishna Chandra Eluri)